Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know
- 31 July 2012
- journal article
- viewpoint
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 71 (11), 1761-1764
- https://doi.org/10.1136/annrheumdis-2012-202021
Abstract
Glucocorticoids are one of the most frequently prescribed therapies in rheumatology, a reflection of their effectiveness as a powerful anti-inflammatory drug. Glucocorticoids are also, however, associated with a wide range of adverse events, particularly at higher doses. To make appropriate decisions, doctors and patients need to weigh these benefits against the potential harms. This article describes the many uncertainties which make informed prescribing difficult. We lack knowledge, for example, on the magnitude of risk, the relationship to dose and duration, and what happens to risk on stopping therapy. Beyond safety, we describe how patients may lack understanding of the nature of the benefits and harms, and how to incorporate value judgements which are crucial to the decision making process. We conclude by exploring how future research might fill these knowledge gaps to enable a better informed decision process.Keywords
This publication has 27 references indexed in Scilit:
- Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)Annals Of The Rheumatic Diseases, 2012
- Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysisAnnals Of The Rheumatic Diseases, 2012
- The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analysesArthritis Research & Therapy, 2011
- Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasisAnnals Of The Rheumatic Diseases, 2010
- Prednisone, Lupus Activity, and Permanent Organ DamageThe Journal of Rheumatology, 2009
- Drug Insight: selective agonists and antagonists of the glucocorticoid receptorNature Clinical Practice Endocrinology & Metabolism, 2008
- EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseasesAnnals Of The Rheumatic Diseases, 2007
- Communicating with Patients about Harms and RisksPLoS Medicine, 2005
- Attitude of rheumatoid arthritis patients to treatment with oral corticosteroidsRheumatology, 2003
- Effect of interpretive bias on research evidenceBMJ, 2003